https://en.sputniknews.africahttps://t.me/sputnik_africa/45638
Breakthrough in Parkinson's Research: Targeting Faulty Protein With Copper Therapy Offers Hope
Breakthrough in Parkinson's Research: Targeting Faulty Protein With Copper Therapy Offers Hope
Sputnik Africa
Breakthrough in Parkinson's Disease Research: Targeting Faulty Protein With Copper Therapy Offers Hope 28.06.2025, Sputnik Africa
2025-06-28T17:04+0200
2025-06-28T17:04+0200
2025-06-28T18:08+0200
sputnik africa
science
research
australia
disease
health
healthcare
https://cdn1.img.sputniknews.africa/img/07e9/06/1c/1074840839_0:67:1280:787_1920x0_80_0_0_ab910a9699db918d4fa6b2dbc13f4fb7.jpg
Breakthrough in Parkinson's Disease Research: Targeting Faulty Protein With Copper Therapy Offers HopeGroundbreaking research by the University of Sydney team revealed a new way of tackling Parkinson's disease by targeting SOD1, a brain protein that normally protects it, but malfunctions in patients and damages brain cells.Key results:Copper therapy targeting SOD1 works: Treating mice bred to have Parkinson-like symptoms with CuATSM, a special copper supplement, dramatically improved their motor skills.Motor decline halted: Mice receiving the copper treatment avoided movement problems and improved their motor skills, unlike those on a placebo."The results were beyond our expectations and suggest, once further studies are carried out, this treatment approach could slow the progression of Parkinson’s disease in humans," said Professor Kay Double, who led the research team.Parkinson's disease is a degenerative brain disorder where dopamine-producing cells die, causing tremors, stiffness, and impaired movement. No cure exists for now.
australia
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
2025
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
News
en_EN
Sputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
https://cdn1.img.sputniknews.africa/img/07e9/06/1c/1074840839_72:0:1209:853_1920x0_80_0_0_224f6c4bfaf1b0ca5d183f938014c5be.jpgSputnik Africa
feedback@sputniknews.com
+74956456601
MIA „Rossiya Segodnya“
sputnik africa, science, research, australia, disease, health, healthcare
sputnik africa, science, research, australia, disease, health, healthcare
Breakthrough in Parkinson's Disease Research: Targeting Faulty Protein With Copper Therapy Offers Hope
Groundbreaking research by the University of Sydney team revealed a new way of tackling Parkinson's disease by targeting SOD1, a brain protein that normally protects it, but malfunctions in patients and damages brain cells.
Copper therapy targeting SOD1 works: Treating mice bred to have Parkinson-like symptoms with CuATSM, a special copper supplement, dramatically improved their motor skills.
Motor decline halted: Mice receiving the copper treatment avoided movement problems and improved their motor skills, unlike those on a placebo.
"The results were beyond our expectations and suggest, once further studies are carried out, this treatment approach could slow the progression of Parkinson’s disease in humans," said Professor Kay Double, who led the research team.
Parkinson's disease is a degenerative brain disorder where dopamine-producing cells die, causing tremors, stiffness, and impaired movement. No cure exists for now.